Category: Static

Temple Health hospital CEO steps down

John Cacciamani, MD, is stepping down from his role as president and CEO of  Philadelphia-based Chestnut Hill Hospital, part of Philadelphia-based Temple Health, effective immediately. 

Dartmouth hospital names interim CEO

Dartmouth Health’s New London (N.H.) Hospital has tapped Lauren Geddes Wirth, MD, to serve as interim president and CEO. 

Healthcare M&A: 10-point status update

It’s gearing up to be another big year for health system mergers and acquisitions. Here’s what Becker’s has gathered on the transactions scene as we settle into 2024: 

40+ systems promote resiliency badge for suppliers

More than four dozen health systems have pledged to adopt the Healthcare Industry Resilience Collaborative’s resiliency badge, which seeks to improve trust between medical suppliers and providers. 

Pennsylvania system taps Medline for prime vendor deal

Lehigh Valley Health Network signed a yearslong agreement for Medline to exclusively service medical supplies to the system’s 13 hospital campuses. 

UCSF expands Hawaii hospital collaborations, part of $150M donation

San Francisco-based UCSF Health is expanding its collaboration with Hawai’i Pacific Health and Hilo (Hawaii) Medical Center after the two received a combined $150 million donation.

UChicago Medicine nurses plan 1-day strike

Members of the National Nurses Organizing Committee, an affiliate of National Nurses United, are set to hold a one-day strike March 14 at UChicago Medicine.

Federal agencies put healthcare deals in spotlight

Several federal agencies are teaming up to launch a cross-government public inquiry into the effects of private equity and other corporations on healthcare.

Viewpoint: CEOs, infection preventionists merit 'best friend' status

Healthcare CEOs may be overlooking a vital ally in their quest to enhance organizational outcomes: infection preventionists, one expert wrote in a March 5 op-ed for Fast Company.

Drugmakers send CMS counteroffers in fair price negotiations

Drugmakers that were selected in early February to begin price negotiations for 10 of the most expensive drugs in the U.S. as part of the Biden administration’s Inflation Reduction Act have sent the federal government counteroffers, President Joe Biden…